Biomarkers are a bridge to the next frontier in immuno-oncology - STAT

Biomarkers are a bridge to the next frontier in immuno-oncology - STAT

Opinion: STAT Plus: Biomarkers provide a bridge to the next frontier in immuno-oncology

By GREY WILKINSON

SAUL LOEB/AFP/GETTY IMAGES

Next-generation cancer therapies work, but not in everyone. Biomarkers can help identify good candidates and track whether a therapy is working.

READ MORE